Critical Comparison: Modular Medical (NASDAQ:MODD) versus Nyxoah (NASDAQ:NYXH)

Modular Medical (NASDAQ:MODD) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Institutional and Insider Ownership

27.5% of Modular Medical shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Modular Medical and Nyxoah’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$13.88 million	($0.97)	-1.75
Nyxoah	$4.70 million	N/A	-$46.77 million	($1.68)	N/A

Modular Medical has higher earnings, but lower revenue than Nyxoah. Modular Medical is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Modular Medical has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500.

Profitability

This table compares Modular Medical and Nyxoah’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-235.93%	-180.37%
Nyxoah	-993.28%	-38.58%	-31.24%

Analyst Recommendations

This is a breakdown of current ratings for Modular Medical and Nyxoah, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	0	0	2	0	3.00
Nyxoah	0	1	5	0	2.83

Modular Medical presently has a consensus target price of $4.25, indicating a potential upside of 150.00%. Nyxoah has a consensus target price of $20.60, indicating a potential upside of ?. Given Nyxoah’s higher probable upside, analysts plainly believe Nyxoah is more favorable than Modular Medical.

Summary

Modular Medical beats Nyxoah on 7 of the 13 factors compared between the two stocks.

About Modular Medical

Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.